Clinical Trials Directory

Trials / Suspended

SuspendedNCT00065572

Exploratory Study to Assess the Biological Activity of ZD6126 in Subjects With Newly Diagnosed Metastatic Renal Cell Carcinoma (Stage IV)

Status
Suspended
Phase
Phase 2
Study type
Interventional
Enrollment
—
Sponsor
AstraZeneca · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to assess the biological activity of ZD6126 in subjects with newly diagnosed metastatic renal cell carcinoma (stage IV).

Conditions

Interventions

TypeNameDescription
DRUGZD6126
DRUGPlacebo

Timeline

Start date
2003-08-01
Primary completion
2004-02-01
Completion
2004-02-01
First posted
2003-07-31
Last updated
2011-01-26

Locations

16 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00065572. Inclusion in this directory is not an endorsement.

Exploratory Study to Assess the Biological Activity of ZD6126 in Subjects With Newly Diagnosed Metastatic Renal Cell Car (NCT00065572) · Clinical Trials Directory